PARP1 |
P09874
|
poly(ADP-ribose) polymerase 1
|
|
3.3E-04 |
0.389 |
0.923 |
CDKN1A |
P38936
|
cyclin dependent kinase inhibitor 1A
|
|
1.9E-03 |
0.403 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
CDKN2C |
P42773
|
cyclin dependent kinase inhibitor 2C
|
|
0.40 |
0.527 |
0.654 |
COL11A2 |
P13942
|
collagen type XI alpha 2 chain
|
|
0.70 |
0.435 |
0.846 |
CRK |
P46108
|
CRK proto-oncogene, adaptor protein
|
|
0.96 |
0.394 |
0.923 |
CRKL |
P46109
|
CRK like proto-oncogene, adaptor protein
|
|
0.45 |
0.553 |
0.769 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
DCC |
P43146
|
DCC netrin 1 receptor
|
|
0.99 |
0.471 |
0.808 |
DES |
P17661
|
desmin
|
|
8.8E-03 |
0.460 |
0.846 |
DNMT3B |
Q9UBC3
|
DNA methyltransferase 3 beta
|
|
0.20 |
0.453 |
0.846 |
EPO |
P01588
|
erythropoietin
|
|
1.1E-02 |
0.381 |
0.885 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
ICAM1 |
P05362
|
intercellular adhesion molecule 1
|
|
3.5E-02 |
0.364 |
0.962 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
IL15 |
P40933
|
interleukin 15
|
|
0.71 |
0.422 |
0.846 |
MB |
P02144
|
myoglobin
|
|
3.1E-02 |
0.556 |
0.731 |
MGMT |
P16455
|
O-6-methylguanine-DNA methyltransferase
|
|
1.2E-07 |
0.412 |
0.885 |
CIITA |
P33076
|
class II major histocompatibility complex transactivator
|
|
1.4E-07 |
0.536 |
0.808 |
PTH |
P01270
|
parathyroid hormone
|
|
1.2E-02 |
0.397 |
0.846 |
AIMP2 |
Q13155
|
aminoacyl tRNA synthetase complex interacting multifunctional protein 2
|
|
8.0E-03 |
0.393 |
0.923 |
TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
GRAP2 |
O75791
|
GRB2 related adaptor protein 2
|
|
1.5E-04 |
0.394 |
0.923 |